歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁(yè) > 小分子抑制劑 > Metabolism > TAK-063

瀏覽歷史

S80213

TAK-063

源葉(MedMol) 98%
  • 英文名:
  • TAK-063
  • 別名:
  • TAK-063; 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)-pyridazin-4(1H)-one; 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)
  • CAS號(hào):
  • 1238697-26-1
  • 分子式:
  • C23H17FN6O2
  • 分子量:
  • 428.4185
  • 核磁/質(zhì)譜:
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫(kù)存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購(gòu)物車(chē)...
源葉(MedMol) S80213-1mg 98% ¥176.80元 10 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80213-2mg 98% ¥312.80元 10 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80213-5mg 98% ¥544.00元 7 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80213-10mg 98% ¥816.00元 5 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80213-25mg 98% ¥1496.00元 4 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80213-50mg 98% ¥2856.00元 預(yù)計(jì)交期:2-3天 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80213-100mg 98% ¥4800.00元 預(yù)計(jì)交期:2-3天 - - - EA 加入購(gòu)物車(chē)
大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(shū)(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說(shuō)明書(shū)。
  • 產(chǎn)品描述: Balipodect (TAK-063) is a highly potent, selective and orally active PDE10A inhibitor with IC50 of 0.30 nM; >15000-fold selectivity over other PDEs
  • 靶點(diǎn): IC50: 0.3 nM (PDE10A);PDE
  • 體內(nèi)研究:
    Balipodect (TAK-063) has excellent selectivity (>15000-fold selectivity over other PDEs), and favorable pharmacokinetics, including high brain penetration, in mice. Oral administration of Balipodect (TAK-063) to mice elevated striatal 3',5'-cyclic adenosine monophosphate (cAMP) and 3',5'-cyclic guanosine monophosphate (cGMP) levels at 0.3 mg/kg and showed potent suppression of phencyclidine (PCP)-induced hyperlocomotion at a minimum effective dose (MED) of 0.3 mg/kg. Balipodect (TAK-063) at 0.3 and 1 mg/kg, p.o., increased cAMP and cGMP levels in the rodent striatum and upregulated phosphorylation levels of key substrates of cAMP-dependent and cGMP-dependent protein kinases. Balipodect (TAK-063) at 0.3 and 1 mg/kg, p.o., strongly suppressed MK-801-induced hyperlocomotion that is often used as a predictive model for antipsychotic-like activity in rodents. Balipodect (TAK-063) did not affect plasma prolactin or glucose levels at doses up to 3 mg/kg, p.o. Balipodect (TAK-063) at 3 mg/kg, p.o., elicited a weak cataleptic response compared with haloperidol and olanzapine
  • 參考文獻(xiàn):
    1. Kunitomo J, et al. Discovery of 1-[2-Fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one (TAK-063), a Highly Potent, Selective, and Orally Active Phosphodiesterase 10A (PDE10A) Inhibitor. J Med Chem. 2014 Nov 26;57 2. Suzuki K, et al. In Vivo Pharmacological Characterization of TAK-063, a Potent and Selective Phosphodiesterase 10A Inhibitor with Antipsychotic-Like Activity in Rodents. J Pharmacol Exp Ther. 2014 Dec 18. pii: jpet.114.218552.
  • 溶解性: soluble  in  DMSO
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.334 ml 11.671 ml 23.342 ml
    5 mM 0.467 ml 2.334 ml 4.668 ml
    10 mM 0.233 ml 1.167 ml 2.334 ml
    50 mM 0.047 ml 0.233 ml 0.467 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷(xiāo)售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷(xiāo)售條款。